Despite technological advancements, many challenges remain in getting a drug from lab to pharmacy shelf. Reframing what is a “medicine” could expand treatment options for researchers and patients.
Academic rigor, journalistic flair
Articles on Pharmaceutics
Displaying all articles
Drug development is a long and costly process that often ends in failure. Improving the way potential drug candidates are optimized could help boost success rates.
The process will take months, if it’s even approved. But just the threat of waiving intellectual property rights could spur faster action.
India and South Africa are pressing the World Trade Organization to waive patent rights to help ramp up vaccine production. There’s a better solution.
Vaccine manufacturing is complex, with lots of potential points for errors. But it also has extensive quality control checks and approvals.
COVID-19 vaccine testing on children is just getting started, and only in adolescents.
In the 1980s, CSIRO and its university collaborators set into motion a chain of events that would lead to the production of relenza, the first drug to successfully treat the flu.
Inspired by amber and hard candy, researchers figured out a new, needle-free, shelf-stable way to preserve vaccines, making them easier to ship and administer around the world.
Top contributors
-
Associate Professor, University of Dayton
-
Associate Dean for Research, Charles Walgreen Jr. Professor of Pharmacy and Pharmaceutical Sciences, University of Michigan
-
Professor of Pharmaceutics, The University of Texas at Austin
-
Visiting Fellow, Swinburne University of Technology
-
Professor of Operations Management & Business Analytics, Carey Business School, Johns Hopkins University
-
Clinical Assistant Professor, Pharmacy Practice, Binghamton University, State University of New York
-
Assistant Professor of History, University at Buffalo
-
Director of Natural Product Discovery Core; Assistant Professor of Medicinal Chemistry, University of Michigan
-
Professor of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus
-
Professor of Innovation Studies, Swinburne University of Technology
-
Assistant Professor of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus
